Condition
Early Stage Lung Cancer (I and II)
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Not Yet Recruiting1
Terminated1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04515004Phase 2TerminatedPrimary
Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer
NCT07409129Not ApplicableNot Yet Recruiting
Tubeless Strategy for Enhanced Recovery After Sublobar Resection
NCT06737107RecruitingPrimary
Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer
Showing all 3 trials